51375-21-4Relevant articles and documents
Novel halogenated nitrobenzylthioinosine analogs as es nucleoside transporter inhibitors
Gupte, Amol,Buolamwini, John K.
, p. 2257 - 2260 (2004)
Nucleoside transporter inhibitors have potential therapeutic applications as anticancer, antiviral, cardioprotective, and neuroprotective agents. We have synthesized and flow cytometrically evaluated the binding affinity of a series of novel halogenated nitrobenzylthioinosine analogs at the human es nucleoside transporter. Structure-activity relationships indicate the importance of hydrophobicity and electron withdrawing capacity of substituents at the para-position of the 6-position benzyl substituent. All of the compounds showed high binding affinity as shown by their ability to displace the fluorescent es transporter ligand, SAENTA-X8-fluorescein. Compound 16 (6-S-(para-iodobenzyl)-6- thioinosine) was the most tightly bound within the series with a Ki of 3.88nM (NBMPR exhibited a Ki of 0.70nM). This compound has higher affinity than the widely used nonnucleoside, nucleoside transport inhibitor, dipyridamole (Ki=8.79nM), and may serve as a new lead compound.